Clinical Trial Update: Study of the Relationship Between rHuEPO Dose, Serum ADPN, and Mortality in Patients Beginning HD

View source ↗

Summary

A terminated clinical trial evaluating the relationship between recombinant human erythropoietin dose, serum ADPN, and mortality in patients beginning hemodialy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Hamamatsu University | Conditions: Renal Dialysis | Status: TERMINATED